Skip to main content

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

Holdings in Q2 2023

Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.

Institution overview
Positions
156
−3 vs. Q1 2023
Portfolio value
$7.01B
+$119.3M (+1.7%) vs. Q1 2023
Filed
Aug 14, 2023
SEC
Holdings of Bellevue Group AG in Q2 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
AXSMAxsome Therapeutics, Inc.COM574,363$41.3M0.6%+133,013+30.1%AddedHistory
ZBHZimmer Biomet Holdings, Inc.Stock284,835$41.5M0.6%+19,565+7.4%AddedHistory
SILKSilk Road Medical IncCOM1,356,763$44.1M0.6%+287,024+26.8%AddedHistory
DHRDanaher CorpStock183,709$44.1M0.6%−153,682−45.6%ReducedHistory
LLYEli Lilly & CoStock95,155$44.6M0.6%+84,391+784.0%AddedHistory
ELVElevance Health, Inc.Stock102,453$45.5M0.6%+9,483+10.2%AddedHistory
APLSApellis Pharmaceuticals, Inc.COM518,495$47.2M0.7%−590,887−53.3%ReducedHistory
EXELExelixis, Inc.COM2,534,000$48.4M0.7%−75,000−2.9%ReducedHistory
HCAHCA Healthcare, Inc.COM160,515$48.7M0.7%−143,271−47.2%ReducedHistory
MOHMolina Healthcare, Inc.COM164,338$49.5M0.7%+21,729+15.2%AddedHistory
TMOThermo Fisher Scientific Inc.Stock96,101$50.1M0.7%+9,768+11.3%AddedHistory
CRSPCRISPR Therapeutics AGNAMEN AKT899,300$50.5M0.7%−500−0.1%ReducedHistory
BIOBio-Rad Laboratories, Inc.CL A134,533$51.0M0.7%+20,794+18.3%AddedHistory
TNDMTandem Diabetes Care IncCOM NEW2,092,934$51.4M0.7%+299,171+16.7%AddedHistory
MGNXMacrogenics IncCOM9,609,913$51.4M0.7%00.0%UnchangedHistory
TMDXTransMedics Group, Inc.COM612,613$51.4M0.7%−16,871−2.7%ReducedHistory
RLAYRelay Therapeutics, Inc.COM4,170,800$52.4M0.7%−1,8000.0%ReducedHistory
ARVNArvinas, Inc.COM2,127,000$52.8M0.8%00.0%UnchangedHistory
VEEVVeeva Systems IncStock271,046$53.6M0.8%+8,061+3.1%AddedHistory
HUMHumana IncStock127,373$57.0M0.8%+58,803+85.8%AddedHistory
IDXXIDEXX Laboratories IncCOM114,441$57.5M0.8%+3,513+3.2%AddedHistory
ALGNAlign Technology IncCOM171,140$60.5M0.9%00.0%UnchangedHistory
ACCDAccolade, Inc.COM4,521,059$60.9M0.9%+479,258+11.9%AddedHistory
CLDXCelldex Therapeutics, Inc.COM NEW1,800,000$61.1M0.9%00.0%UnchangedHistory
CRLCharles River Laboratories International, Inc.COM314,513$66.1M0.9%+12,067+4.0%AddedHistory
OMOutset Medical, Inc.COM3,125,886$68.4M1.0%+219,127+7.5%AddedHistory
INSMINSMED IncCOM PAR $.013,300,911$69.6M1.0%+7,809+0.2%AddedHistory
OPCHOption Care Health, Inc.COM NEW2,287,623$74.3M1.1%−154,562−6.3%ReducedHistory
SWAVShockwave Medical, Inc.COM270,526$77.2M1.1%−10,850−3.9%ReducedHistory
PENPenumbra IncCOM234,220$80.6M1.1%−3,952−1.7%ReducedHistory
BDXBecton Dickinson & CoStock337,723$89.2M1.3%−10,320−3.0%ReducedHistory
PODDInsulet CorpStock323,594$93.3M1.3%00.0%UnchangedHistory
EXASExact Sciences CorpCOM1,006,772$94.5M1.3%−218,270−17.8%ReducedHistory
DXCMDexcom IncCOM761,716$97.9M1.4%+6,637+0.9%AddedHistory
EWEdwards Lifesciences CorpStock1,038,092$97.9M1.4%−2,577−0.2%ReducedHistory
PACBPacific Biosciences of California, Inc.COM7,542,829$100.3M1.4%+516,723+7.4%AddedHistory
UNHUnitedHealth Group IncStock210,127$101.0M1.4%+15,316+7.9%AddedHistory
EVHEvolent Health, Inc.CL A3,448,322$104.5M1.5%+1,257,175+57.4%AddedHistory
AXNXAxonics, Inc.COM2,223,418$112.2M1.6%+311,557+16.3%AddedHistory
AGIOAgios Pharmaceuticals, Inc.COM4,013,500$113.7M1.6%00.0%UnchangedHistory
INSPInspire Medical Systems, Inc.COM357,020$115.9M1.7%−20,048−5.3%ReducedHistory
MDTMedtronic plcStock1,410,492$124.3M1.8%+181,257+14.7%AddedHistory
RVMDRevolution Medicines, Inc.COM4,746,000$127.0M1.8%−1,9000.0%ReducedHistory
BSXBoston Scientific CorpStock2,661,452$144.0M2.1%−778,127−22.6%ReducedHistory
SYKStryker CorpStock476,946$145.5M2.1%−7,828−1.6%ReducedHistory
SAGESage Therapeutics, Inc.COM3,114,375$146.4M2.1%+24,375+0.8%AddedHistory
INCYIncyte CorpCOM2,640,765$164.4M2.3%−199,735−7.0%ReducedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM899,650$170.9M2.4%+16,400+1.9%AddedHistory
ABTAbbott LaboratoriesStock1,646,501$179.5M2.6%−4150.0%ReducedHistory
MRNAModerna, Inc.Stock1,525,059$185.3M2.6%−26,647−1.7%ReducedHistory
ITCIIntra-Cellular Therapies, Inc.COM3,201,800$202.7M2.9%−66,200−2.0%ReducedHistory
NBIXNeurocrine Biosciences IncStock2,612,800$246.4M3.5%−5000.0%ReducedHistory
ISRGIntuitive Surgical IncCOM NEW842,224$288.0M4.1%−126,562−13.1%ReducedHistory
ARGXArgenx SESPONSORED ADR923,284$359.8M5.1%+36,356+4.1%AddedHistory
IONSIonis Pharmaceuticals IncCOM9,380,300$384.9M5.5%−131,600−1.4%ReducedHistory
VRTXVertex Pharmaceuticals IncStock1,097,166$386.1M5.5%−48,529−4.2%ReducedHistory

Sold out since Q1 2023 (12)

Positions held at the end of Q1 2023 that are gone from this filing.

Positions of Bellevue Group AG sold out since Q1 2023
SecurityClassShares in Q1 2023Value in Q1 2023% of portfolio in Q1 2023History
PFEPfizer IncStock740,695$30.2M0.4%History
HALOHalozyme Therapeutics, Inc.COM742,400$28.4M0.4%History
BNTXBioNTech SESPONSORED ADS196,480$24.5M0.4%History
HRMYHarmony Biosciences Holdings, Inc.COM598,046$19.5M0.3%History
ZLABZai Lab LtdADR159,400$5.30M0.1%History
ISEEIVERIC bio, Inc.COM52,900$1.29M<0.1%History
CAHCardinal Health IncStock10,600$800.3K<0.1%History
XNCRXencor IncCOM25,400$708.4K<0.1%History
CYVNYOpthea LtdSPONSORED ADS47,000$186.1K<0.1%History
IPGPIpg Photonics CorpCOM1,050$129.5K<0.1%History
BMYBristol Myers Squibb CoStock1,496$103.7K<0.1%History
HSICHenry Schein IncCOM1,043$85.0K<0.1%History